CSL112 (Apolipoprotein A-I (Human)) Infusion in Post Myocardial Infarction Patients Promotes Hepatocyte Cholesterol Uptake Ex Vivo

被引：0
|
作者：
Velkoska, Elena
Greene, Brandon
Collins, Heidi L.
Adelman, Steven
Mears, Jenny
Duffy, Danielle
Gibson, C. Michael
Diditchenko, Svetlana
Kingwell, Bronwyn A.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11305
引用
收藏
页数：2
相关论文
共 36 条
  • [31] CSL112, A Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Patients With Stable Atherothrombotic Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study
    Gille, Andreas
    D'Andrea, Denise
    Easton, Rachel
    Tricoci, Pierluigi
    Alexander, John H.
    Wright, Samuel D.
    Shear, Charles L.
    CIRCULATION, 2013, 128 (22)
  • [32] CSL112, a Novel Formulation of Human Apolipoprotein A-I, Provides Sustained Increases in Biomarkers of Cholesterol Transport Following Repeat Dosing: A Placebo-Controlled, Randomized Multiple Ascending Dose Study in Healthy Subjects
    Gille, Andreas
    Easton, Rachael
    Wright, Samuel
    Shear, Charles
    CIRCULATION, 2012, 126 (21)
  • [33] CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction
    Didichenko, Svetlana A.
    Velkoska, Elena
    Navdaev, Alexei V.
    Greene, Brandon H.
    Lorkowski, Shuhui Wang
    Duffy, Danielle
    Mears, Sojaita J.
    Wright, Samuel D.
    Gibson, C. Michael
    Smith, Jonathan D.
    Kingwell, Bronwyn A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (06) : 855 - 869
  • [34] The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Human APOA-I, After Acute Myocardial Infarction - The APOA-I Event Reduction in Ischemic Syndromes I (AEGIS-I) Trial
    Gibson, C. Michael
    Korjian, Serge
    Tricoci, Pierluigi
    Daaboul, Yazan
    Alexander, John H.
    Steg, Philippe G.
    Lincoff, A. M.
    Kastelein, John J.
    Mehran, Roxana
    D'Andrea, Denise
    Merkely, Bela
    Zarebinski, Maciej
    Ophius, Ton Oude
    Harrington, Robert A.
    CIRCULATION, 2016, 134 (25) : E706 - E706
  • [35] Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction
    Cubedo, Judit
    Padro, Teresa
    Badimon, Lina
    TRANSLATIONAL RESEARCH, 2014, 164 (03) : 209 - 222
  • [36] Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction
    Gibson, C. Michael
    Korjian, Serge
    Tricoci, Pierluigi
    Daaboul, Yazan
    Alexander, John H.
    Steg, Philippe G.
    Lincoff, A. Michael
    Kastelein, John J. P.
    Mehran, Roxana
    D'Andrea, Denise
    Merkely, Bela
    Zarebinski, Maciej
    Ophius, Ton Oude
    Harrington, Robert A.
    AMERICAN HEART JOURNAL, 2016, 180 : 22 - 28
1234